Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.07. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
03.07. | Sharps Technology ernennt Paul Danner zum Executive Chairman und aktualisiert Vorstandsrollen | 4 | Investing.com Deutsch | ||
03.07. | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
09.06. | Sharps Technology Inc: Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025 | 4 | GlobeNewswire (USA) | ||
04.06. | Aktie von Sharps Technology steigt nach ersten kommerziellen Lieferungen | 1 | Investing.com Deutsch | ||
04.06. | Sharps Technology stock soars on first commercial shipments | 4 | Investing.com | ||
04.06. | Why Is Sharps Technology Stock Soaring On Wednesday? | 4 | Benzinga.com | ||
SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
04.06. | Pre-market Movers: Baosheng Media, Sharps Technology, New Century Logistics, NewGenIvf Group, Bon Natural Life | 541 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green Baosheng Media Group Holdings Limited (BAOS) is... ► Artikel lesen | |
04.06. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
04.06. | Sharps Technology Inc: Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements | 2 | GlobeNewswire (USA) | ||
22.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
22.05. | Sharps Technology regains compliance with Nasdaq's listing rules | 1 | Seeking Alpha | ||
22.05. | Sharps Technology Inc: Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule | 188 | GlobeNewswire (Europe) | NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
15.05. | Sharps Technology Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
07.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
30.04. | Pre-market Movers: Regulus Therapeutics, Jeffs' Brands, INVO Fertility, GeneDx Holdings, Sharps Technology | 821 | AFX News | TEMPE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Regulus Therapeutics Inc. (RGLS) is up over 132%... ► Artikel lesen | |
30.04. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
30.04. | Sharps Technology receives $400K initial purchase order | 2 | Seeking Alpha | ||
24.04. | Sharps Technology announces 1-for-300 reverse stock split; shares down | 8 | Seeking Alpha | ||
24.04. | Sharps Technology Inc: Sharps Technology Announces Reverse Stock Split | 790 | GlobeNewswire (Europe) | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
STRATEC | 26,550 | -0,38 % | Stratec-Aktie kann Vortagsniveau nicht halten (26,65 €) | Im deutschen Wertpapierhandel notiert das Wertpapier von Stratec derzeit etwas leichter. Die Aktie kostete zuletzt 26,65 Euro. Am Aktienmarkt liegt der Anteilsschein von Stratec zur Stunde im Minus.... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,120 | +0,84 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,626 | -5,44 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update | FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No Additional Toxicity Studies Required
Strong... ► Artikel lesen | |
PING AN HEALTHCARE | 1,415 | -2,92 % | HSI Closes Midday at 24,929, Up 22 pts; HSTI Closes Midday at 5,438, Down 21 pts; KUAISHOU-W Down over 6%; CH MODERN D, BRILLIANCE CHI, YOURAN DAIRY, PA GOODDOCTOR, REALORD GROUP Hit New Highs | ||
MOUNTAIN VALLEY MD | 0,012 | -6,06 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,220 | +0,92 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,950 | +3,60 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
VERU | 0,298 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA8959792018 Trilogy AI Corp. 08.08.2025 CA88909Q1090 Tokenwell Platforms Inc. 11.08.2025 Tausch 1:1US92536C1036 Veru... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,668 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
EKSO BIONICS | 2,910 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 5,990 | +1,53 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.08.2025 | Das Instrument 9YG NO0010955917 DEEP VAL.DRILL.AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.08.2025 und ex Kapitalmassnahme am 07.08.2025 The instrument 9YG NO0010955917 DEEP VAL.DRILL.AS... ► Artikel lesen | |
BEYOND AIR | 3,160 | 0,00 % | Beyond Air: Umsatzsprung bei deutlicher Gewinnverfehlung | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,422 | +0,84 % | Novacyt S.A. - Liquidity Agreement Monthly Update & TVR |